The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...

Large-scale compounding facilities have to stop making tirzepatide, the main ingredient in blockbuster obesity drug Zepbound, Wednesday.

A new study suggests blockbuster weight loss drugs Wegovy and Zepbound are not cost-effective at their current prices, despite the proven health benefits. The study, published in JAMA Health Forum and ...

Jim Cramer recently talked about the market selloff and how years of profits are lost within days when panic hits the market: ...

When it comes to clinical weight-loss treatments, GLP-1 therapies have taken the medical sector by storm. What started as off ...

For decades, the United States has led the world in pharmaceutical innovation -- developing drugs that combat cancer, heart disease, AIDS, diabetes and other ...

Even a little weight loss can work wonders for your health. A study found that people at high risk for developing type 2 diabetes who lost 5-7% of their weight had a 58% lower risk of developing it.

The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...

It is unclear whether Robert F. Kennedy Jr. knew about the raid. Also, the FDA is documenting injuries caused by nitrous oxide sold commercially, as inhaling it can cause dangerously low blood ...

People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...